Szczepanska-Konkel M, Hoppe A, Lin J T, Dousa T P
Department of Physiology and Biophysics, Mayo Clinic and Foundation, Mayo Medical School, Rochester, Minnesota 55905.
Am J Physiol. 1990 Apr;258(4 Pt 1):C583-8. doi: 10.1152/ajpcell.1990.258.4.C583.
We investigated the suitability of alpha-bromophosphonoacetic acid (alpha-BrPAA) to act as a possible irreversible inhibitor of Na(+)-dependent transport of Pi across renal brush-border membrane (BBM). When added directly into the Pi uptake medium, alpha-BrPAA causes specific, competitive [apparent inhibition constant (Ki) = 0.33 mM; no change in maximum velocity (Vmax)], and reversible (by washing) inhibition of Na+ gradient [Na+o greater than Na+i]-dependent uptake of Pi by BBM vesicles (BBMV). Next, BBMV were preincubated with 5 mM alpha-BrPAA in alkaline (pH 9) medium for 30 min, then twice washed by 1:100 dilution and recentrifugation, and tested for transport and other properties. This preincubation of BBMV with alpha-BrPAA in alkaline medium resulted in a different type of inhibition [lower Vmax; no change in Michaelis constant (Km)] of the Na+ gradient-dependent uptake of 32Pi, whereas the uptakes of D-[3H]glucose and other solutes were not altered. This inhibition of Pi transport was not reversed by dilution and washing of BBMV. The BBMV Na(+)-dependent binding of [14C]phosphonoformic acid, but not of [3H]phlorizin, was decreased; activities of BBM marker enzymes were not changed. Results suggest that alpha-BrPAA binds onto the same locus on luminal surface of BBM on which Pi and Na+ bind and inhibits Na(+)-Pi cotransporter similar to phosphonoformic acid. Furthermore, after a 30-min incubation in alkaline medium, alpha-BrPAA apparently forms a more stable association with BBM in the vicinity of the Na(+)-Pi cotransporter. We thus suggest that alpha-BrPAA acts under these conditions as an apparently irreversible inhibitor of Na(+)-Pi cotransporter in BBM.(ABSTRACT TRUNCATED AT 250 WORDS)
我们研究了α-溴代膦酰基乙酸(α-BrPAA)作为一种可能的不可逆抑制剂,抑制肾脏刷状缘膜(BBM)上Na⁺依赖的无机磷(Pi)转运的适用性。当直接添加到Pi摄取培养基中时,α-BrPAA会引起特异性、竞争性[表观抑制常数(Ki)=0.33 mM;最大速度(Vmax)无变化],并且对BBM囊泡(BBMV)中Na⁺梯度[细胞外Na⁺大于细胞内Na⁺]依赖的Pi摄取产生可逆(通过洗涤)抑制作用。接下来,将BBMV在碱性(pH 9)培养基中与5 mM α-BrPAA预孵育30分钟,然后通过1:100稀释和再次离心洗涤两次,并测试其转运和其他特性。在碱性培养基中用α-BrPAA对BBMV进行这种预孵育,导致对Na⁺梯度依赖的³²Pi摄取产生不同类型的抑制作用[Vmax降低;米氏常数(Km)无变化],而D-[³H]葡萄糖和其他溶质的摄取未改变。这种对Pi转运的抑制作用不会通过BBMV的稀释和洗涤而逆转。BBMV对[¹⁴C]膦酰基甲酸的Na⁺依赖结合减少,但对[³H]根皮苷的结合未减少;BBM标记酶的活性未改变。结果表明,α-BrPAA与BBM腔表面上Pi和Na⁺结合的同一位点结合,并类似于膦酰基甲酸抑制Na⁺-Pi共转运体。此外,在碱性培养基中孵育30分钟后,α-BrPAA显然在Na⁺-Pi共转运体附近与BBM形成更稳定的结合。因此,我们认为在这些条件下,α-BrPAA作为BBM中Na⁺-Pi共转运体的一种明显不可逆抑制剂起作用。(摘要截短至250字)